The Wall Street Journal: TB's Global Resurgence Amplifies U.S. Risk
Multidrug-resistant TB is at epidemic proportions in some parts of the world -- a growing problem the U.S. is surprisingly unprepared for. The U.S. beat back multidrug-resistant tuberculosis in the 1990s. Today, however, a new threat is emerging as drug resistance worsens abroad and far more dangerous strains develop and spread, including some that are all but untreatable with standard drugs (McKay, 12/18).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.